Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigating the structural impact of Omicron RBD mutation on antibody escape and receptor management.

Journal of biomolecular structure & dynamics - 1 Jun 2024

Saini Samvedna, Pareekh Savita, Kumar Yatender

Abstract excerpt

The SARS-CoV-2 Variant B.1.1.5291 evolved rapidly in late November 2021 from the existing mutants sparking fear worldwide owing to its infamous immune escape from a varied class of neutralising antibodies. To assess the structural behaviour of Omicron-Receptor Binding Domain (RBD) upon interacting with cross-reactive CR3022 antibody, we investigated the computational approach of structural engagement in B.1.1529...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune Evasion

Share to Molecular Docking Simulation

Share to Molecular Dynamics Simulation

Share to Protein Interaction Domains and Motifs

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Identifiers

PMID: 37334729
DOI: 10.1080/07391102.2023.2222174

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigating the structural impact of Omicron RBD mutation on antibody escape and receptor management.PMID 37334729Read ↗

Integrative Computational Modeling of Distinct Binding Mechanisms for Broadly Neutralizing Antibodies Targeting SARS-CoV-2 Spike Omicron Variants: Balance of Evolutionary and Dynamic Adaptability in Shaping Molecular Determinants of Immune EscapeSemantic proximity Read ↗

Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants.Semantic proximity Read ↗

Structure-Guided Design of Therapeutic Antibodies Targeting SARS-CoV-2 Omicron VariantsSemantic proximity Read ↗

Affinity maturation of cross-reactive CR3022 antibody against the receptor binding domain of SARS-CoV-2 via in silico site-directed mutagenesisSemantic proximity Read ↗

Structural insight into antibody evasion of SARS-CoV-2 omicron variantSemantic proximity Read ↗

Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain.Semantic proximity Read ↗

Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapiesSemantic proximity Read ↗

Impact of BA.1, BA.2, and BA.4/BA.5 Omicron mutations on therapeutic monoclonal antibodies.Semantic proximity Read ↗

Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variantsSemantic proximity Read ↗

Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsSemantic proximity Read ↗

Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape.Semantic proximity Read ↗

Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.